18983288589(微信同号)
18983288589(微信同号)
18908392210(微信同号)
18980413049
ChiCTR1900020656
尚未开始
/
/
/
2019-01-12
/
/
結直腸癌
Effectiveness of a mhealth Intervention for Increasing Colonoscopy Uptake among Chinese First-degree Relatives of People with Colorectal Cancer
Effectiveness of a mhealth Intervention for Increasing Colonoscopy Uptake among Chinese First-degree Relatives of People with Colorectal Cancer
This study aims to develop a tailored risk communication intervention (TRCI) based on results of the systematic review on interventions to promote colonoscopy screening conducted by the principal investigator, and examine its effectiveness in promoting colonoscopy uptake among Chinese first-degree relatives (FDRs).
随机平行对照
卫生服务研究
Each family will be randomly assigned to TRSI group or control group with a 1:1 ratio using a sequence of block randomization number to assign cluster numbers equally to each group. A statistician will generates a random number sequence by computer software, a randomly mixed block size at 4-8 will b
Due to the nature of the intervention, blinding of participants and researchers is impossible. To avoid biased estimated of treatment effect, online survey will be conducted.?Participant will submit the web form back to the web server directly when the finish the assessment and the intervener are not able to influence the assessment.
N/A
/
105
/
2019-03-04
2019-10-31
/
(1) aged 40-75 years or 10 years before the age the relative was diagnosed; (2) individuals with 1 FDR with CRC at <60 years or with 2 or more FDRs with CRC at any age; (3) have not had a colonoscopy before; (4) with access to We-chat themselves or through close family members living in the same household; (5)able to read and speak Chinese. (6) living in Shenzhen;
登录查看(1) have history of cancer or inflammatory bowel disease; (2) recently participate in another study or previously participated in cancer risk counseling or study; (3) with doctor-diagnosed psychiatric illness.;
登录查看香港中文大學醫學院那打素護理學院
/
药明康德2024-10-25
药渡2024-10-25
医麦客2024-10-25
小药说药2024-10-25
触界生物2024-10-24
磐霖资本2024-10-24
Pharma CMC2024-10-24
Pharma CMC2024-10-24
瑞博小核酸2024-10-24
君实医学2024-10-24